MedTrace Logo

FSH Treatment for Non-obstructive Azoospermic Patients

NCT02275169 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2015-02-02

No results posted yet for this study

Summary

Aim of the study is to evaluate the effect of highly purified human follicle-stimulating hormone treatment on the chance of retrieving testicular sperm (sperm retrieval rate) from infertile male patients with non-obstructive azoospermia of unknown origin.

Conditions

  • Azoospermia

Interventions

DRUG

Urofollitropin

Urofollitropin 75 IU 2 ampoules three times a week for three months

OTHER

Placebo

Placebo ampoules administered three times a week for three months

Sponsors & Collaborators

  • Minia University

    collaborator OTHER

  • Azienda Sanitaria Locale Bari

    lead OTHER

Principal Investigators

  • Ettore Caroppo, MD · ASL Bari

  • Craig Niederberger, MD · University at Illinois at Chicago UIC College of Medicine

  • Alayman Hussein, MD · El Minia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-02-29
Completion
2016-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02275169 on ClinicalTrials.gov